Network-Based Transcriptome Analysis Reveals FAM3C as a Novel Potential Biomarker for Glioblastoma.

MLA

Chagas, Pablo Shimaoka, et al. “Network-Based Transcriptome Analysis Reveals FAM3C as a Novel Potential Biomarker for Glioblastoma.” Journal of Cellular Biochemistry, vol. 125, no. 8, Aug. 2024, p. e30612. EBSCOhost, https://doi.org/10.1002/jcb.30612.

APA

Chagas, P. S., Chagas, H. I. S., Naeini, S. E., Bhandari, B., Gouron, J., Malta, T. M., Salles, É. L., Wang, L. P., Yu, J. C., & Baban, B. (2024). Network-Based Transcriptome Analysis Reveals FAM3C as a Novel Potential Biomarker for Glioblastoma. Journal of Cellular Biochemistry, 125(8), e30612. https://doi.org/10.1002/jcb.30612

Chicago

Chagas, Pablo Shimaoka, Henrique Izumi Shimaoka Chagas, Sahar Emami Naeini, Bidhan Bhandari, Jules Gouron, Tathiane M Malta, Évila Lopes Salles, Lei P Wang, Jack C Yu, and Babak Baban. 2024. “Network-Based Transcriptome Analysis Reveals FAM3C as a Novel Potential Biomarker for Glioblastoma.” Journal of Cellular Biochemistry 125 (8): e30612. doi:10.1002/jcb.30612.